Recurrent ventilator-associated pneumonia in severe Covid-19 ARDS patients requiring ECMO support.
Elena Collado-LledóQuentin MoyonJuliette ChommelouxMarc Pineton de ChambrunGuillaume HékimianOuriel SauraDavid LévyMatthieu SchmidtAlain CombesCharles-Edouard LuytLucie Le FevrePublished in: Annals of intensive care (2024)
In patients with severe Covid-19-ARDS requiring ECMO support, VAP recurrence occurs frequently, with Enterobacteriaceae and Pseudomonas aeruginosa as predominant causative microorganisms. An antimicrobial treatment of ≥ 8 days for the treatment of first VAP episode did not reduce the risk of VAP recurrence, as compared to shorter duration.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- pseudomonas aeruginosa
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- early onset
- mechanical ventilation
- staphylococcus aureus
- peritoneal dialysis
- free survival
- prognostic factors
- drug induced
- drug resistant
- replacement therapy
- urinary tract infection